Literature DB >> 32761237

Endovascular Thrombectomy for Pediatric Acute Ischemic Stroke: A Multi-Institutional Experience of Technical and Clinical Outcomes.

Vijay M Ravindra1,2,3, Matthew Alexander4, Philipp Taussky1, Robert J Bollo1, Ameer E Hassan5,6, Jonathan P Scoville1, Julius Griauzde7, Al-Wala Awad1, Mouhammad Jumaa8,9, Syed Zaidi8,9, Jonathan J Lee10, Muhammad Ubaid Hafeez11, Fábio A Nascimento11, Melissa A LoPresti2, William T Couldwell1, Steven W Hetts12, Sandi K Lam2, Peter Kan2, Ramesh Grandhi1.   

Abstract

BACKGROUND: Endovascular thrombectomy is a promising treatment for acute ischemic stroke in children, but outcome and technical data in pediatric patients with large-vessel occlusions are lacking.
OBJECTIVE: To assess technical and clinical outcomes of thrombectomy in pediatric patients.
METHODS: We undertook a retrospective cohort study of pediatric patients who experienced acute ischemic stroke from April 2017 to April 2019 who had immediate, 30-, and 90-d follow-up. Patients were treated with endovascular thrombectomy at 5 US pediatric tertiary care facilities. We recorded initial and postprocedural modified Thrombolysis in Cerebral Infarction (mTICI) grade ≥ 2b, initial and postprocedural Pediatric National Institutes of Health Stroke Scale (PedNIHSS) score, and pediatric modified Rankin scale (mRS) score 0 to 2 at 90 d.
RESULTS: There were 23 thrombectomies in 21 patients (mean age 11.6 ± 4.9 yr, median 11.5, range 2.1-19; 52% female). A total of 19 (83%) thrombectomies resulted in mTICI grade ≥ 2b recanalization. The median PedNIHSS score was 13 on presentation (range 4-33) and 2 (range 0-26) at discharge (mean reduction 11.3 ± 6.1). A total of 14 (66%) patients had a mRS score of 0 to 2 at 30-d follow-up; 18/21 (86%) achieved that by 90 d. The median mRS was 1 (range 0-4) at 30 d and 1 (range 0-5) at 90 d. One patient required a blood transfusion after thrombectomy.
CONCLUSION: In this large series of pediatric patients treated with endovascular thrombectomy, successful recanalization was accomplished via a variety of approaches with excellent clinical outcomes; further prospective longitudinal study is needed.
Copyright © 2020 by the Congress of Neurological Surgeons.

Entities:  

Keywords:  Anticoagulation; Cerebrovascular; Endovascular; Ischemic stroke; Pediatrics; Thrombectomy

Mesh:

Year:  2020        PMID: 32761237     DOI: 10.1093/neuros/nyaa312

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  4 in total

1.  Endovascular mechanical thrombectomy in a child with COVID-19: Clot analysis reveals a novel pathway in the neuroinflammatory cascade resulting in large-vessel occlusion.

Authors:  Vijay M Ravindra; Frederik Denorme; Matthew D Alexander; Robert A Campbell; Ramesh Grandhi
Journal:  Interv Neuroradiol       Date:  2022-04-21       Impact factor: 1.764

2.  Acute StrokeTreatment in Children: Are Adult Guidelines Applicable?

Authors:  Sudeepta Dandapat; Waldo R Guerrero; Santiago Ortega-Gutierrez
Journal:  Curr Treat Options Neurol       Date:  2022-02-19       Impact factor: 3.972

Review 3.  The Genetic Basis of Strokes in Pediatric Populations and Insight into New Therapeutic Options.

Authors:  Milena Jankovic; Bojana Petrovic; Ivana Novakovic; Slavko Brankovic; Natasa Radosavljevic; Dejan Nikolic
Journal:  Int J Mol Sci       Date:  2022-01-29       Impact factor: 5.923

4.  Successful thrombectomy in a pediatric patient with large vessel occlusion and COVID-19 related multisystem inflammatory syndrome.

Authors:  Lisa M Pabst; Stephanie A Zyck; Patrick Youssef
Journal:  Interv Neuroradiol       Date:  2022-02-15       Impact factor: 1.610

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.